Nutrition News

Gluten-free products have significantly different nutritional composition than their counterparts that contain gluten, which could especially impact children with celiac disease, according to research presented at the European Society for Pediatric Gastroenterology, Hepatology and Nutrition annual meeting.

Almost 1 billion people worldwide may have deficient or insufficient levels of vitamin D, due to chronic disease, use of sunscreen, inadequate dietary sources, and malabsorption, according to an evidence-based clinical review published in the Journal of the American Osteopathic Association.

CHICAGO — The enzyme known as aspergillus niger-derived prolyl endoprotease, or AN-PEP, shows promise for protecting gluten-sensitive patients from experiencing symptoms after exposure to small amounts of gluten, according to research presented at Digestive Disease Week.

Randomized controlled trials of the low FODMAP diet for irritable bowel syndrome carry a high risk for bias and have insufficient follow-up, and the improvements in symptoms observed in these trials could be driven by a placebo response, according to new research published in Alimentary Pharmacology and Therapeutics.

Researchers associated high-quality dietary patterns defined by four different diet quality indexes with a reduced risk for colorectal cancer across a number of racial and ethnic groups.

Adding oats to increase the nutritional value of a gluten-free diet does not appear to affect symptoms, histology, immunity or serologic features of patients with celiac disease, according to new research published in Gastroenterology.

Higher dietary intake of rice bran and navy beans resulted in changes to the gut microbiome and reduced colorectal cancer cell growth in colorectal cancer survivors, according to the results of a randomized controlled trial presented at the American Association for Cancer Research Annual Meeting.

ORLANDO, Fla. — Childhood undernutrition is the leading cause of death in children under age 5 years worldwide, and disturbances in the early life gut microbiota may hold clues to solving a vexing epidemic, according to a speaker here.

RP-G28, a non-digestible oligosaccharide designed to stimulate the gut microbiota to metabolize lactose, improved abdominal symptoms in patients with lactose intolerance in a phase 2b/3 trial, the manufacturer announced.

The FDA has issued marketing clearance to a new enteral nutrition delivery device designed to simplify the administration of tube feeding formulas, the manufacturer announced.